| Ticker Details |
CareDx, Inc.
CareDx Inc is a commercial stage company. It develops, markets and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime.
|
| IPO Date: |
July 17, 2014 |
| Sector: |
Healthcare |
| Industry: |
Diagnostics and Research |
| Market Cap: |
$966.93M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.62 | 3.05%
|
| Avg Daily Range (30 D): |
$0.54 | 2.74%
|
| Avg Daily Range (90 D): |
$0.46 | 2.54%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.53M |
| Avg Daily Volume (30 D): |
.53M |
| Avg Daily Volume (90 D): |
.69M |
| Trade Size |
| Avg Trade Size (Sh.): |
77 |
| Avg Trade Size (Sh.) (30 D): |
49 |
| Avg Trade Size (Sh.) (90 D): |
56 |
| Institutional Trades |
| Total Institutional Trades: |
3,445 |
| Avg Institutional Trade: |
$2.33M |
| Avg Institutional Trade (30 D): |
$1.63M |
| Avg Institutional Trade (90 D): |
$1.82M |
| Avg Institutional Trade Volume: |
.09M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.82M |
| Avg Closing Trade (30 D): |
$1.99M |
| Avg Closing Trade (90 D): |
$2.09M |
| Avg Closing Volume: |
117.68K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$.03
|
$-.16
|
|
Diluted EPS
|
|
$.03
|
$-.16
|
|
Revenue
|
|
$100.06M
|
$86.68M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
|
$1.68M
|
$-8.57M
|
|
Operating Income / Loss
|
|
$-.25M
|
$-11.12M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
|
$23.23M
|
$-20.52M
|
|
PE Ratio
|
|
|
|
|
|
|
